BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:Announcing the inaugural Advanced Therapies Integrates event - enabling strategic debate and collaboration across the Advanced Therapie s and Medicinal Products (ATMP) Industry\n\nLondon\, UK\, 1st October&nbs p\;2021 \;/ Sciad \;Newswire / \;Life Science Integrates (LSI ) \;is \;delighted to announce the inaugural Advanced Therapies I ntegrates event on 7th October 2021\, hosted live online in partnership w ith The Cell and Gene Therapy Catapult.\n\nThe past years have seen an in tense global focus on healthcare like never before. Life Science Integrat es aims to facilitate the translation of cutting-edge research and innova tion into the widespread adoption of Advanced Therapies to improve patien t outcomes and revolutionize healthcare economics.\n\nThis event will con stitute a new forum\, bringing together industry leaders to deliver the f ull potential of ATMPs. Pharmaceutical innovations are taking place at an astonishing pace. Advances in areas such as genomics have seen the emerg ence of highly effective but complex therapeutics\, including cell and ge ne therapies\, regenerative medicines and tissue therapies.\n\nWhile thes e innovations offer transformative potential to healthcare globally\, str ategic challenges remain surrounding the development\, deployment and uti lisation of these ground-breaking medical technologies.\n\nFocusing on th ree core themes of Trending Technology\, Novel Networks &\; Finance\, and Produce and Use\, the event addresses key questions for the developme nt of the industry such as:\n\n\nHow good are we at making Advanced Thera pies today? What should the future look like?\nHow can we expand the deve lopment and use of autologous ATMPs?\nAre we doing enough to put investme nts and infrastructure in place to rapidly translate ATMPs from concept t o clinic?\n\nWith over 70 expert speakers\, the event will uniquely engag e across the widest possible network from pharma innovators\, regulators\ , equipment &\; technology providers\, academia\, industry association s\, and governing bodies.\n\nLSI are delighted to announce that the conte nt-packed agenda will be initiated with opening remarks from Dr Sharon Br ownlow\, Chief Business Officer at the Cell and Gene Therapy Catapult. Th e Cell and Gene Therapy Catapult bridges the gap between research and ful l-scale commercialisation to ensure a thriving UK industry can deliver li fe-changing advanced therapies to the world. With an academic background in biophysics and postdoctoral research\, followed by 30 years’ experienc e in biotechnology\, Sharon’s contribution to the event is not to be miss ed. “I am looking forward to the opportunity offered by Advanced Therapie s Integrates to come together with experts from across the industry to ad dress key topics across manufacturing\, regulatory\, supply chain and mor e\, that will enable the UK to continue to build a strong advanced therap ies ecosystem and continue to forge powerful collaborations\,” stated Sha ron.\n\n“Coming together to share our industry insights facilitates many additional conversations that will no doubt lead to new and exciting coll aborations over the coming months and years\,” commented LSI Co-Founder a nd Executive Director\, Samuel Thangiah. “The team at Life Science Integr ates sincerely thank all this year’s speakers\, sponsors and partners for contributing towards what promises to be such a rich and varied conferen ce.”\n\nView the full agenda and register now for the very first Advanced Therapies Integrates event.\n DTEND;VALUE=DATE:20211007 DTSTAMP:20260512T220027Z DTSTART;VALUE=DATE:20211007 LOCATION:\, SEQUENCE:0 SUMMARY:Announcing the inaugural Advanced Therapies Integrates event - ena bling strategic debate and collaboration across the Advanced Therapies an d Medici... UID:9fd0718c-7054-4105-b0a5-bbad0e3fb6e2 END:VEVENT END:VCALENDAR